Development of New Antithrombotic Regimens for Patients with Acute Coronary Syndrome

Patients with acute coronary syndrome (ACS) require long-term antithrombotic intervention to reduce the risk of further ischemic events; dual antiplatelet therapy with a P2Y(12) inhibitor and acetylsalicylic acid (ASA) is the current standard of care. However, pivotal clinical trials report that pat...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Sudhakar, Onwordi, Eunice N. C., Gamal, Amr, Zaman, Azfar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555775/
https://www.ncbi.nlm.nih.gov/pubmed/30972665
http://dx.doi.org/10.1007/s40261-019-00769-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555775/
https://www.ncbi.nlm.nih.gov/pubmed/30972665
http://dx.doi.org/10.1007/s40261-019-00769-6

Ejemplares similares